Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients. KRAS mutations are known to be a driver event of PDAC, but targeting mutant KRAS has proved challenging. Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases. Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling. Here we explore the role of mutant KRAS in PDAC maintenance using a recently developed inducible mouse model of mutated Kras (Kras(G12D), herein KRas) in a p53(LoxP/WT) background. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of the KRAS pathway and mitochondrial respiration to manage pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies have demonstrated that genetic ablation of KRAS expression leads to cell cycle arrest and death in cell lines and potent tumor regressions in animal models of PDAC (5–7).”
From Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with this notion, other complex I inhibitors have shown efficacy as anti-tumor agents (Appleyard et al., 2012; Schockel et al., 2015) and may show selective toxicity against oncogene-ablation resistant cells (Viale et al., 2014) and cancer stem cells (Sancho et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recurrent theme in studies on cancer progression is the increased reliance of cancer cells on OXPHOS in advanced stages of disease.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a mouse pancreatic cancer model, ablating oncogenic Kras from established tumors revealed a fraction of cells that survive and eventually propagate.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Self-citationTransmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationHematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Self-citation
Cited by
Items 701–800 of 1,000
Braun, L. M., Lagies, S., Klar, R. F. U., Hussung, S., Fritsch, R., Kammerer, B., & Wittel, U. A. (2020) · Cancers · doi:10.3390/cancers12061440 · Cited by 26
Targeting the metabolism of cancer stem cells by energy disruptor molecules
Dadgar, T., Ebrahimi, N., Gholipour, A. R., Akbari, M., Khani, L., Ahmadi, A., & Hamblin, M. R. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103545 · Cited by 23
Noh, J. K., Woo, S. R., Kong, M., Lee, M. K., Lee, J. W., Lee, Y. C., Ko, S., & Eun, Y. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13328 · Cited by 30
Padinharayil, H., Rai, V., & George, A. (2023) · Cancers · doi:10.3390/cancers15041070 · Cited by 30
Yan, C., Gao, R., Gao, C., Hong, K., Cheng, M., Liu, X., Zhang, Q. H., & Zhang, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1105117 · Cited by 22
S-Nitrosylation at the intersection of metabolism and autophagy: Implications for cancer
Guil‐Luna, S., Sánchez-Montero, M. T., & Rodríguez‐Ariza, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189012 · Cited by 24
Yang, K., Zhong, Z., Zou, J., Liao, J., Chen, S., Zhou, S., Zhao, Y., Li, J., Yin, D., Huang, K., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216840 · Cited by 24
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles
Blanco, V., Latif, T., Chu, Z., & Qi, X. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.03.011 · Cited by 23
ANGPTL4 T266M variant is associated with reduced cancer invasiveness
Tan, Z. W., Teo, Z. Q., Tan, C., Choo, C. C., Loo, W. S., Song, Y., Tam, Z. Y., Ng, S. P., Koh, D. H. Z., Ng, Y. S., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.06.010 · Cited by 23
ZFX Promotes Proliferation and Metastasis of Pancreatic Cancer Cells via the MAPK Pathway
Song, X., Zhu, M., Zhang, F., Zhang, F., Zhang, Y., Hu, Y., Jiang, L., Hao, Y., Chen, S., Zhu, Q., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491727 · Cited by 22
Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis
Kim, M. S., Gernapudi, R., Cedeno, Y. C., Polster, B. M., Martinez, R., Shapiro, P., Kesari, S., Nurmemmedov, E., & Passaniti, A. (2020) · Oncotarget · doi:10.18632/oncotarget.27743 · Cited by 26
Mitochondrial Inhibition: a Treatment Strategy in Cancer?
Bueno, M. J., Ruiz-Sepulveda, J. L., & Quintela-Fandiño, M. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01033-x · Cited by 26
López‐Ayllón, B. D., Marín, S., Fernández, M. F., García‐García, T., Fernández‐Rodríguez, R., de Lucas‐Rius, A., Redondo, N., Mendoza‐García, L., Foguet, C., Grigas, J., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29752 · Cited by 29
Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma
Lee, C.-R., Suh, J., Jang, D., Jin, B.-Y., Cho, J., Lee, M., Sim, H., Kang, M., Lee, J., Park, J. H., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01291-2 · Cited by 24
Rubinstein, J. C., Domanskyi, S., Sheridan, T., Sanderson, B. J., Park, S., Kaster, J., Li, H., Anczuków, O., Herlyn, M., & Chuang, J. H. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0690 · Cited by 24
Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities
Zhang, J., Jinan, Z., & Chen, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06063-0 · Cited by 26
Sciver, R. E. V., Lee, M., Lee, C., Lafever, A., Svyatova, E. A., Kanda, K., Collier, A. L., van Reesema, L. L. S., Tang-Tan, A. M., Zheleva, V. P., et al. (2018) · Cancers · doi:10.3390/cancers10050142 · Cited by 21
Metabolic Constrains Rule Metastasis Progression
Roda, N., Gambino, V., & Giorgio, M. (2020) · Cells · doi:10.3390/cells9092081 · Cited by 23
Effects of metabolic cancer therapy on tumor microenvironment
Hyroššová, P., Milošević, M., Škoda, J., Vachtenheim, J., Jr., Rohlena, J., & Rohlenová, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1046630 · Cited by 25
PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models
Park, K. C., Kim, J. M., Kim, S. Y., Kim, S., Lim, J. H., Kim, M. K., Fang, S., Kim, Y., Mills, G. B., Noh, S. H., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02727-8 · Cited by 20
Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression
Ogunleye, A. O., Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2023) · Stem Cells · doi:10.1093/stmcls/sxad017 · Cited by 24
Genetics of enzymatic dysfunctions in metabolic disorders and cancer
Mahé, M., Rios-Fuller, T. J., Karolin, A., & Schneider, R. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1230934 · Cited by 26
Figarol, S., Delahaye, C., Gence, R., Doussine, A., Cerapio, J., Brachais, M., Tardy, C., Béry, N., Asslan, R., Colinge, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49360-4 · Cited by 28
Senft, D., & Jeremias, I. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.09.006 · Cited by 25
Animal models for modeling pancreatic cancer and novel drug discovery
Bisht, S., & Feldmann, G. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1566319 · Cited by 22
Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor
Huang, W., Gao, J., Chen, Z., Shi, H., Yuan, J., Cui, H., Yeh, C., Bränström, R., Larsson, C., Li, S., et al. (2020) · Cells · doi:10.3390/cells9061333 · Cited by 21
Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics
Zhang, X., Milito, A. D., Demiroglu‐Zergeroglu, A., Gullbo, J., D’Arcy, P., & Linder, S. T. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.10.009 · Cited by 22
Understanding the autophagic functions in cancer stem cell maintenance and therapy resistance
Niharika, N., & Garg, M. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.23 · Cited by 25
Vijay, V., Karisani, N., Shi, L., Hung, Y.-H., Vu, P., Kattel, P., Kenney, L., Merritt, J., Adil, R., Wu, Q., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1383 · Cited by 23
Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cells
Naik, P. P., Panigrahi, S., Parida, R., Praharaj, P. P., Bhol, C. S., Patil, S., Manjunath, N., Ghosh, D., Patra, S. K., & Bhutia, S. K. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10216-9 · Cited by 20
Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy
Saliakoura, M., Sebastiano, M. R., Nikdima, I., Pozzato, C., & Konstantinidou, G. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02231-y · Cited by 22
Abnormal lipid synthesis as a therapeutic target for cancer stem cells
Wang, S., Hu, Q., Wu, T., Xia, J., Tao, X., & Cheng, B. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i2.146 · Cited by 22
Oliva, C. R., Ali, M. Y., Flor, S., & Griguer, C. E. (2022) · Cell Stress · doi:10.15698/cst2022.04.266 · Cited by 23
Mitochondrial respiratory complexes: Significance in human mitochondrial disorders and cancers
Vikramdeo, K. S., Sudan, S. K., Singh, A. P., Singh, S., & Dasgupta, S. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30869 · Cited by 23
Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities
Sarwar, A., Zhu, M., Su, Q., Zhu, Z., Yang, T., Chen, Y., Peng, X., & Zhang, Y. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103858 · Cited by 22
Le, X. T., Lee, J., Nguyen, N. T., Lee, W. T., Lee, E. S., Oh, K. T., Choi, H., Shin, B. S., & Youn, Y. S. (2022) · Biomaterials Science · doi:10.1039/d2bm01281b · Cited by 20
The role of cancer cell bioenergetics in dormancy and drug resistance
Tau, S. S., & Miller, T. W. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10081-7 · Cited by 26
Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence
Alhasan, B. A., Mikeladze, M. A., Guzhova, I. V., & Margulis, B. A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10085-3 · Cited by 22
Pouliquen, D., Gall‐Tros̆elj, K., & Anto, R. J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061612 · Cited by 24
Sun, T., Song, C., Zhao, G., Feng, S., Wei, J., Zhang, L., Liu, X., Li, Z., & Zhang, H. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06335-5 · Cited by 22
Han, H., He, T., Wu, Y., He, T., & Zhou, W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1441081 · Cited by 23
Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment
Singh, M. K., Han, S., Kim, S. S., & Kang, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011185 · Cited by 26
Targeting Autophagy in ALK-Associated Cancers
Frentzel, J., Sorrentino, D., & Giuriato, S. (2017) · Cancers · doi:10.3390/cancers9120161 · Cited by 21
Kitazawa, M., Hatta, T., Sasaki, Y., Fukui, K., Ogawa, K., Fukuda, E., Goshima, N., Okita, N. T., Yamada, Y., Nakagama, H., et al. (2019) · Cancer Science · doi:10.1111/cas.14275 · Cited by 22
Beta 1 integrin signaling mediates pancreatic ductal adenocarcinoma resistance to MEK inhibition
Brannon, A., Drouillard, D., Steele, N. G., Schoettle, S., Abel, E. V., Crawford, H. C., & di Magliano, M. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-67814-9 · Cited by 19
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
Amano, T., Murakami, A., Murakami, T., & Chano, T. (2021) · Antioxidants · doi:10.3390/antiox10020187 · Cited by 22
Functional States in Tumor-Initiating Cell Differentiation in Human Colorectal Cancer
Zowada, M. K., Tirier, S. M., Dieter, S. M., Krieger, T. G., Oberlack, A., Chua, R. L., Huerta, M., Ten, F. W., Laaber, K., Park, J., et al. (2021) · Cancers · doi:10.3390/cancers13051097 · Cited by 26
Wu, H., Jia, P., Zou, Y., & Jiang, J. (2021) · Biomaterials Science · doi:10.1039/d1bm00589h · Cited by 20
Clinical Translation of Combined MAPK and Autophagy Inhibition in RAS Mutant Cancer
Lee, J. J., Jain, V., & Amaravadi, R. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212402 · Cited by 23
Sasaki, A., Nagatomo, K., Ono, K., Yamamoto, T., Otsuka, Y., Teshima, T., & Yamada, K. (2015) · Human Cell · doi:10.1007/s13577-015-0125-3 · Cited by 21
Vitto, H. D., Ryu, J., Calderón-Aparicio, A., Monts, J., Dey, R., Chakraborty, A., Lee, M., Bode, A. M., & Dong, Z. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00234-5 · Cited by 20
Liu, Y., Al‐Adra, D. P., Lan, R., Jung, G., Li, H., Yeh, M. M., & Liu, Y. (2022) · Hepatology Communications · doi:10.1002/hep4.1945 · Cited by 21
Sriramkumar, S., Metcalfe, T. X., Lai, T., Zong, X., Fang, F., O’Hagan, H. M., & Nephew, K. P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271584 · Cited by 19
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy
Cao, J., Zhang, Z., Zhou, L., Luo, M., Li, L., Li, B., Nice, E. C., He, W., Zheng, S., & Huang, C. (2023) · MedComm · doi:10.1002/mco2.427 · Cited by 22
Varuzhanyan, G., Chen, C., Freeland, J., Tian, H., Tran, W., Song, K., Wang, L., Cheng, D., Xu, S., DiBernardo, G., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2416882121 · Cited by 24
Zhou, X., Xiong, Z., Xiao, S., Zhou, J., Ding, Z., Ling-chao, T., Chen, X.-D., Xu, R., & Zhao, P. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s148681 · Cited by 18
RetractedThe Intricate Metabolism of Pancreatic Cancers
Camelo, F., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_5 · Cited by 21
The second genome: Effects of the mitochondrial genome on cancer progression
Scheid, A. D., Beadnell, T. C., & Welch, D. R. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.01.001 · Cited by 22
Kou, L., Wei, S., & Kou, P. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.733463 · Cited by 22
Öztürk, H., Cingoz, H., Tufan, T., Yang, J., Adair, S. J., Tummala, K. S., Kuscu, C., Kinali, M., Cömertpay, G., Nagdas, S., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.04.014 · Cited by 19
Cao, X., Cao, Y., Zhao, H., Wang, P., & Zhu, Z. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220827113434 · Cited by 18
NRBF2-mediated autophagy contributes to metabolite replenishment and radioresistance in glioblastoma
Kim, J., Kang, H., Son, B., Kim, M., Kang, J., Park, K. H., Jeon, J., Jo, S., Kim, H. Y., Youn, H., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00873-2 · Cited by 21
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
Parisotto, M., Vuong, N., Kalegari, P., Meharwade, T., Joumier, L., Igelmann, S., Bourdeau, V., Rowell, M., Pollak, M., Malleshaiah, M. K., et al. (2022) · Cancers · doi:10.3390/cancers14225597 · Cited by 24
A Review of Advances in Mitochondrial Research in Cancer
Li, Z., Zhang, W., Guo, S., Qi, G., Huang, J., Gao, J., Zhao, J., Kang, L., & Li, Q. (2024) · Cancer Control · doi:10.1177/10732748241299072 · Cited by 22
The autophagy-related genes Beclin1 and LC3 in the prognosis of pancreatic cancer.
Cui, L., Wang, X., Zhao, X., Kong, C., Li, Z., Liu, Y., Jiang, X., & Zhang, X. (2019) · Europe PMC (PubMed Central) · Cited by 18
RetractedShen, S., Yan, Z., Wu, J., Liu, X., Guan, G., Zou, C., Guo, Q., Zhu, C., Liu, T., Chen, C., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.581197 · Cited by 18
Polygoni Multiflori Radix Preparat Delays Skin Aging by Inducing Mitophagy
Liu, X., Yang, C., Deng, Y., Liu, P., Yang, H., Du, X., & Du, Y. (2021) · BioMed Research International · doi:10.1155/2021/5847153 · Cited by 19
Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells
Nobile, M. S., Votta, G., Palorini, R., Spolaor, S., Vitto, H. D., Cazzaniga, P., Ricciardiello, F., Mauri, G., Alberghina, L., Chiaradonna, F., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz868 · Cited by 21
Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and in vivo metastasis
Rolver, M. G., Roda, J. C., Dai, Y., Flinck, M., Ialchina, R., Hindkær, J., Dyhr, R. T., Bodilsen, A. N., Prasad, N. S., Baldan, J., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111956 · Cited by 21
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
Raufi, A. G., Liguori, N. R., Carlsen, L., Parker, C., Borrero, L. J. H., Zhang, S., Tian, X., Louie, A. D., Zhou, L., Seyhan, A. A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.751568 · Cited by 23
Conquering oncogenic KRAS and its bypass mechanisms
Hou, P., & Wang, Y. (2022) · Theranostics · doi:10.7150/thno.71260 · Cited by 23
Self-citationReyes‐Castellanos, G., Hadi, N. A., Gallardo-Arriaga, S., Masoud, R., Garcia, J., Lac, S., Kaoutari, A. E., Gicquel, T., Planque, M., Fendt, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106899 · Cited by 17
Impact of Opioids on Cellular Metabolism: Implications for Metabolic Pathways Involved in Cancer
Tarazi, D., & Maynes, J. T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092225 · Cited by 17
Role of Vitamin C in Targeting Cancer Stem Cells and Cellular Plasticity
Lee, Y. (2023) · Cancers · doi:10.3390/cancers15235657 · Cited by 20
Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer
Wang, Y., Harada‐Shoji, N., Kitamura, N., Yamazaki, Y., Ebata, A., Amari, M., Watanabe, M., Miyashita, M., Tada, H., Abe, T., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.6987 · Cited by 21
Self-citationTiwari, M., Srivastava, P., Abbas, S., Jegatheesan, J., Ranjan, A., Sharma, S., Maurya, V. P., Saxena, A. K., & Sharma, L. K. (2024) · Cells · doi:10.3390/cells13050447 · Cited by 19
Navrátilová, J., Karasová, M., Lánová, M. K., Moráňová, L., Budková, Z., Pacherník, J., Šmarda, J., & Beneš, P. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13106 · Cited by 19
Beyond the unwinding: role of TOP1MT in mitochondrial translation
Baechler, S. A., Rosa, I. D., Spinazzola, A., & Pommier, Y. G. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1646563 · Cited by 20
Proteostasis Dysregulation in Pancreatic Cancer
Arpalahti, L., Haglund, C., & Holmberg, C. I. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_4 · Cited by 18
Mitochondria-driven elimination of cancer and senescent cells
Hubáčková, S., Novais, S. M., Davidová, E., Neužil, J., & Rohlena, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0256 · Cited by 20
Educate, not kill: treating cancer without triggering its defenses
Škarková, A., Bizzarri, M., Janoštiak, R., Mašek, J., Rösel, D., & Brábek, J. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.04.003 · Cited by 21
Aberrant Energy Metabolism in Tumors and Potential Therapeutic Targets
Fan, S., Guo, J., Nie, H., Xiong, H., & Xia, Y. (2024) · Genes Chromosomes and Cancer · doi:10.1002/gcc.70008 · Cited by 21
Cancer dormancy and metabolism: From molecular insights to translational opportunities
Wang, Y., Liu, L., Zhang, X., Liang, T., & Bai, X. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218097 · Cited by 21
Self-citationRerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers
Moss, D., McCann, C. K., & Kerr, E. M. (2022) · Science Signaling · doi:10.1126/scisignal.abj3490 · Cited by 18
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma
Borankova, K., Krchniaková, M., Leck, L. Y. W., Kubistova, A., Neradil, J., Jansson, P. J., Hogarty, M. D., & Skoda, J. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06278-x · Cited by 17
Sunassee, E. D., Deutsch, R. J., D’Agostino, V. W., Castellano‐Escuder, P., Siebeneck, E. A., Ilkayeva, O., Crouch, B. T., Madonna, M. C., Everitt, J. I., Alvarez, J. V., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj7540 · Cited by 17
An, Y., Zhao, F., Jia, H., Meng, S., Zhang, Z., Li, S., & Zhao, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-01789-9 · Cited by 16
Reprogramming Oxidative Phosphorylation in Cancer: A Role for RNA-Binding Proteins
Esparza‐Moltó, P. B., & Cuezva, J. M. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7988 · Cited by 18
Anania, S., Peiffer, R., Rademaker, G., Hego, A., Thiry, M., Deldicque, L., Francaux, M., Maloujahmoum, N., Agirman, F., Bellahcène, A., et al. (2020) · Cancers · doi:10.3390/cancers12061643 · Cited by 21
Organotypic Culture of Acinar Cells for the Study of Pancreatic Cancer Initiation
Carrer, A., & Paoli, C. (2020) · Cancers · doi:10.3390/cancers12092606 · Cited by 21
Kim, I., Kim, M., Park, M. K., Naik, R., Park, J. H., Kim, B., Choi, Y., Chang, K. Y., Won, M., Ban, H. S., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00523-5 · Cited by 16
Transcriptional Regulation of Stem Cell and Cancer Stem Cell Metabolism
Alptekin, A., Ye, B., & Ding, H. (2017) · Current Stem Cell Reports · doi:10.1007/s40778-017-0071-y · Cited by 17
Basal metabolic state governs AIF-dependent growth support in pancreatic cancer cells
Scott, A. J., Wilkinson, A. S., & Wilkinson, J. C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2320-3 · Cited by 18
Silva-Pavez, E., Mendoza, E., Morgado-Cáceres, P., Ahumada-Castro, U., Bustos, G., Kangme-Encalada, M., de Arbina, A. L., Puebla-Huerta, A., Muñoz, F., Cereceda, L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-64228-9 · Cited by 17
Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks
Tsai, K. K., Chan, T., & Shaked, Y. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050702 · Cited by 17
Alfaifi, A., Bahashwan, S., Alsaadi, M., Malhan, H. M., Aqeel, A., Al-Kahiry, W., Almehdar, H. A., & Qadri, I. (2022) · Diagnostics · doi:10.3390/diagnostics12020394 · Cited by 18
Madonna, M. C., Duer, J. E., McKinney, B. J., Sunassee, E. D., Crouch, B. T., Ilkayeva, O., Hirschey, M. D., Alvarez, J. V., & Ramanujam, N. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00481-3 · Cited by 16
Fu, J., Liu, G., Zhang, X., Lei, X., Liu, Q., Qian, K., Tong, Q., Qin, W. D., Li, Z., Cao, Z., et al. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-022-00583-x · Cited by 18
Qian, J., Zhang, X., Wei, B., Tang, Z., & Zhang, B. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188943 · Cited by 17
The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention
Domínguez-Zorita, S., & Cuezva, J. M. (2023) · Cancers · doi:10.3390/cancers15153775 · Cited by 17
Metadata
- Authors
- Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., Kost-Alimova, M., Muller, F., Colla, S., Nezi, L., Genovese, G., Deem, A. K., Kapoor, A., Yao, W., Brunetto, E., Kang, Y., Yuan, M., Asara, J. M., Wang, Y. A., Heffernan, T. P., Kimmelman, A. C., Wang, H., Fleming, J. B., Cantley, L. C., DePinho, R. A., & Draetta, G. F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Weill Cornell Medicine (US)
- IRCCS Ospedale San Raffaele (IT)
- Beth Israel Deaconess Medical Center (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Viale, Andrea
- Draetta, Giulio F.
- ORCID
- Viale, Andrea
- Pettazzoni, Piergiorgio
- Lyssiotis, Costas A.
- Ying, Haoqiang
- Sánchez, Nora
- Marchesini, Matteo
- Carugo, Alessandro
- Seth, Sahil
- Giuliani, Virginia
- Colla, Simona
- Nezi, Luigi
- Genovese, Giannicola
- Deem, Angela K.
- Yao, Wantong
- Brunetto, Emanuela
- Kang, Ya’an
- Yuan, Min
- Asara, John M.
- Wang, Y. Alan
- Heffernan, Timothy P.
- Kimmelman, Alec C.
- Wang, Huamin
- Fleming, Jason B.
- Cantley, Lewis C.
- DePinho, Ronald A.
- Draetta, Giulio F.
- Venue
- Nature
- Published
- 2014-08-10
- Volume
- 514
- Issue
- 7524
- Pages
- 628-632
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4376130
- OpenAlex
- W2023300506
- Semantic Scholar
- 819eeeb41f6e84dd5c00221a269e91238736c4ad
- Cited by
- 1,259
- References
- 125
- Citations by year
- 2026: 93 · 2025: 72 · 2024: 104 · 2023: 105 · 2022: 119 · 2021: 131 · 2020: 135 · 2019: 114 · 2018: 105 · 2017: 90 · 2016: 99 · 2015: 81 · 2014: 8
- FWCI
- 44.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA127003, CA-16672, CA 016672, P01CA120964, P30CA016672, P01CA117969)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, KRAS mutation, tumor recurrence, oxidative phosphorylation, mitochondrial respiration, cancer stem cells, autophagy, glycolysis, OXPHOS inhibitors, combination therapy
- MeSH terms
- Animals, Autophagy, Cell Survival, Disease Models, Animal, Female, Glycolysis, Lysosomes, Mitochondria, Mutation, Neoplasm Recurrence, Local, Oxidative Phosphorylation, Pancreatic Neoplasms, Recurrence, Neoplastic Stem Cells, Signal Transduction, Gene Expression Regulation, Neoplastic, Genes, p53, Proto-Oncogene Proteins p21(ras), Cell Respiration, Carcinoma, Pancreatic Ductal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.